Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Asirvatham

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Drugs|March 13, 2020
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled TrialMala Dharmalingam, S R Aravind, Hemant Thacker, et al.
The Journal of the Association of Physicians of India|June 24, 2025
Expert Consensus on Lifestyle Modifications in Hypertension Management: An Indian PerspectiveJagdish Hiremath, Gurpreet S Wander, Arup Dasbiswas, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Drugs|March 13, 2020
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled TrialMala Dharmalingam, S R Aravind, Hemant Thacker, et al.
The Journal of the Association of Physicians of India|June 24, 2025
Expert Consensus on Lifestyle Modifications in Hypertension Management: An Indian PerspectiveJagdish Hiremath, Gurpreet S Wander, Arup Dasbiswas, et al.
Pageof 2